BioSpace News Archive

Two publicly traded companies to offer distinct opportunities for investment and growth

Wellness Workdays, a leading provider of corporate wellness programs, announces that 14 organizations achieved 2019 Best Wellness Employer gold certification

89bio LTD announced that preclinical data regarding BIO89-100, a novel long-acting glycopegylated fibroblast growth factor 21 analogue for the treatment of NASH, has been selected for a late-breaking poster presentation at The International Liver Congress™ 2019, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria, April 10-14.

New Full Service Physician Package provides tailored wealth management, business and personal banking services, and advice

The Leukemia & Lymphoma Society of Canada is proud to kick off its first-ever Man & Woman of the Year campaign.

Objective brain function assessment system revolutionizes the ABCs of cognitive function

Agreement with Health House for distribution of Satipharm CBD Gelpell® Capsules throughout Australia, New Zealand and Asia.

Absolute Total Care and Pee Dee Community Action Partnership held two outreach events in March for the residents of Sellers and Nichols, South Carolina.

United Neuroscience announced an upcoming presentation on Phase IIa results of its lead clinical product, UB-311, at the 14th International Conference on Alzheimer’s and Parkinson’s Diseases in Lisbon, Portugal, from March 26-31, 2019.

Cardax, Inc. announced results for the year ended December 31, 2018, in its Annual Report on Form 10-K filed today with the SEC.